2-127569793-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001393586.1(MYO7B):c.475G>A(p.Glu159Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,607,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001393586.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7B | NM_001393586.1 | c.475G>A | p.Glu159Lys | missense_variant | 6/48 | ENST00000409816.8 | NP_001380515.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7B | ENST00000409816.8 | c.475G>A | p.Glu159Lys | missense_variant | 6/48 | 1 | NM_001393586.1 | ENSP00000386461.3 | ||
MYO7B | ENST00000428314.5 | c.475G>A | p.Glu159Lys | missense_variant | 6/47 | 5 | ENSP00000415090.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000408 AC: 10AN: 245218Hom.: 0 AF XY: 0.0000375 AC XY: 5AN XY: 133270
GnomAD4 exome AF: 0.0000179 AC: 26AN: 1455466Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 723870
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.475G>A (p.E159K) alteration is located in exon 6 (coding exon 5) of the MYO7B gene. This alteration results from a G to A substitution at nucleotide position 475, causing the glutamic acid (E) at amino acid position 159 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at